India weighs red warning labels on cough syrups for young children
India’s drug regulator is considering mandatory red warnings and child-age pictorials on cough-syrup packs to discourage use in children below four. The proposal, pending committee deliberation, could reshape OTC pharmacy packaging, shelf communication and marketing ahead of a potential April 2026 rollout.
What happened
retail-company · India’s drug regulator is considering mandatory red warning labels and child-age pictorials on cough syrup bottles to deter use in children
Key facts
- Below 4 years
- Below 2 years
- October 2025
- April 2026
- Rule 96 of the Drugs Rules, 1945
What changed
India’s drug regulator is considering mandatory red warning labels and child-age pictorials on cough syrup bottles to deter use in children below four, potentially affecting OTC pharmacy sales, packaging and marketing.
Why this matters
Prepare OTC pharmacy planograms, staff guidance and digital product content for prominent under-four cough-syrup warnings if India mandates the proposed labels by April 2026.
What to watch
- Drug regulator committee recommendation and publication of draft labelling language.
- Whether warnings apply to all cough-and-cold syrups or only specified active ingredients, fixed-dose combinations or dosage forms.
- Final definition of the affected age group and whether the threshold remains below four years.
- Notification date, sell-through provisions for old packs and any April 2026 enforcement deadline.
- Supplier announcements of redesigned packs, discontinued pediatric SKUs or price increases tied to compliance.